Agilon Health, Inc. (AGL)
115.66
+5.36
(+4.86%)
USD |
NYSE |
Nov 13, 16:00
115.65
-0.01
(-0.01%)
After-Hours: 19:59
Agilon Health Price to Book Value : 6.916 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 6.916 |
| November 12, 2026 | 6.595 |
| November 11, 2026 | 6.865 |
| November 10, 2026 | 6.788 |
| November 09, 2026 | 6.818 |
| November 06, 2026 | 6.780 |
| November 05, 2026 | 6.803 |
| November 04, 2026 | 5.754 |
| November 03, 2026 | 5.249 |
| November 02, 2026 | 5.18 |
| October 30, 2026 | 5.077 |
| October 29, 2026 | 5.139 |
| October 28, 2026 | 5.441 |
| October 27, 2026 | 5.420 |
| October 26, 2026 | 5.402 |
| October 23, 2026 | 5.364 |
| October 22, 2026 | 5.399 |
| October 21, 2026 | 5.441 |
| October 20, 2026 | 5.484 |
| October 19, 2026 | 5.312 |
| October 16, 2026 | 5.090 |
| October 15, 2026 | 5.289 |
| October 14, 2026 | 5.226 |
| October 13, 2026 | 5.136 |
| October 12, 2026 | 5.112 |
| Date | Value |
|---|---|
| October 09, 2026 | 4.926 |
| October 08, 2026 | 5.066 |
| October 07, 2026 | 5.124 |
| October 06, 2026 | 4.987 |
| October 05, 2026 | 5.040 |
| October 02, 2026 | 5.031 |
| October 01, 2026 | 4.920 |
| September 30, 2026 | 4.759 |
| September 29, 2026 | 5.765 |
| September 28, 2026 | 5.867 |
| September 25, 2026 | 5.956 |
| September 24, 2026 | 5.594 |
| September 23, 2026 | 6.238 |
| September 22, 2026 | 6.406 |
| September 21, 2026 | 6.494 |
| September 18, 2026 | 6.578 |
| September 17, 2026 | 6.578 |
| September 16, 2026 | 6.614 |
| September 15, 2026 | 6.796 |
| September 14, 2026 | 6.815 |
| September 11, 2026 | 6.622 |
| September 10, 2026 | 6.831 |
| September 09, 2026 | 6.904 |
| September 08, 2026 | 6.740 |
| September 04, 2026 | 6.529 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Astrana Health, Inc. | 1.831 |
| Starling Oncology, Inc. | -- |
| Nakamoto, Inc. | 0.2829 |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 12.59 |
Price to Book Value Related Metrics
| PS Ratio | 0.3282 |
| Price | 115.66 |
| Earnings Yield | -5.69% |
| Market Cap | 1.943B |